Organizations
Conferences
Info & Opinion
January 8, 2009
The comments from Relsys were made before the recent FDA announcement about drug safety.
Like the aftershocks from an earthquake, the political tremors after Vioxx don’t seem to subside. Yes, Merck’s strategy of swatting the pesky plaintiff lawyer-flies one at a time seems to be paying off. And yes, the FDA’s attempt to bolster…
No articles available